The Duke Early Phase Clinical Research Unit is a 30-bed, hospital-based Phase I research unit that conducts early phase studies that require constant patient surveillance. Early Phase has an embedded anesthesiology suite for pharmacology studies, a registry of more than 4000 normal healthy volunteers and a recruitment service.
Researchers seeking clinical expertise and operational capacity to translate preclinical discoveries, new technologies, or device prototypes to humans can collaborate with Duke Early Phase Clinical Research to conduct a broad range of early phase, proof-of-concept, and first-in-human studies.
We partner with pharmaceutical, biotech, medical device, government agencies, foundations, technology companies, and academic centers to accelerate the availability of therapies, diagnostics, technologies, and medical devices to patients.
Our thought leaders optimize clinical trial design to increase operational efficiencies while maintaining regulatory compliance.
At a Glance:
- 34-bed unit, one of the largest academic early phase units in the country
- 50+ personnel experienced in early phase clinical research
- Data analytics/reporting (including PK/PD modeling) that meets FDA reporting standards
- Large healthy and patient volunteer registry
Collaborate with Early Phase:
Contact Juan Martinez at firstname.lastname@example.org or (919) 384-6418 with details about your research question and needs. You will receive a response within 24 hours.